Patients undergoing long-term highly active antiretroviral therapy treatment are probably at a higher risk of various HIV-related complications. Hyperactivation of The mammalian target of rapamycin (mTOR) has been found to contribute to dysregulated apoptosis and autophagy which determine CD4(+)-T-cell loss, impaired function of innate immunity and development of neurocognitive disorders. Dysregulated mTOR activation has also been shown to play a key part in the development of nephropathy and in the pathogenesis of HIV-associated malignancies. These studies strongly support a multifunctional key role for mTOR in the pathogenesis of HIV-related disorders and suggest that specific mTOR inhibitors could represent a novel approach for the prevention and treatment of these pathologies
mTOR as a multifunctional therapeutic target in HIV infection / F. Nicoletti, P. Fagone, P. Meroni, J. McCubrey, K. Bendtzen. - In: DRUG DISCOVERY TODAY. - ISSN 1359-6446. - 16:15-16(2011 Aug), pp. 715-721. [10.1016/j.drudis.2011.05.008]
mTOR as a multifunctional therapeutic target in HIV infection
P. Meroni;
2011
Abstract
Patients undergoing long-term highly active antiretroviral therapy treatment are probably at a higher risk of various HIV-related complications. Hyperactivation of The mammalian target of rapamycin (mTOR) has been found to contribute to dysregulated apoptosis and autophagy which determine CD4(+)-T-cell loss, impaired function of innate immunity and development of neurocognitive disorders. Dysregulated mTOR activation has also been shown to play a key part in the development of nephropathy and in the pathogenesis of HIV-associated malignancies. These studies strongly support a multifunctional key role for mTOR in the pathogenesis of HIV-related disorders and suggest that specific mTOR inhibitors could represent a novel approach for the prevention and treatment of these pathologiesFile | Dimensione | Formato | |
---|---|---|---|
Drug Discov Today 2011 715.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
239.23 kB
Formato
Adobe PDF
|
239.23 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.